Michael Cerminaro is the founder of Thrombolex. Thrombolex has raised $50M in total funding. Latest round: Series A. Backed by OrbiMed.
Michael Cerminaro is the CEO of Thrombolex, a medical device company specializing in endovascular catheters for treating thrombosis. He took over the CEO position from Marvin Woodall and is currently focused on securing significant institutional funding for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library